MB Bangų terapija Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
37,550 |
- |
897 |
852 |
- |
0.02 |
0.05 |
59.41 |
2.27 |
852 |
45 |
0 |
897 |
2022 |
---|
48,267 |
- |
-6,607 |
-6,607 |
- |
-0.12 |
-1.06 |
-0.97 |
-13.69 |
-5,755 |
6,095 |
0 |
340 |
2023 |
---|
101,566 |
- |
6,226 |
5,946 |
- |
0.00 |
1.47 |
18.50 |
5.85 |
190 |
280 |
0 |
470 |
Register and
explore Okredo data2023 |
---|
101,566 |
- |
6,226 |
5,946 |
- |
0.00 |
1.47 |
18.50 |
5.85 |
190 |
280 |
0 |
470 |
Register and
explore Okredo data2023
Turnover (€)
101,566 €110 % *
Sales per employee (€)
-Profit before tax (€)
6,226 €194 % *
Net Profit (€)
5,946 €190 % *
Profit per employee (€)
-Working capital requirement
0.00 100.00 % *
Debt-to-equity ratio
1.47 238.68 % *
Total profitability (%)
18.50 %2,007.22 % *
Net profitability (%)
5.85 %142.73 % *
Equity (€)
190 €103 % *
Amounts Payable And Liabilities (€)
280 €-95 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
470 €38 % *